Funding for this research was provided by:
American Institute for Cancer Research (318258)
Cancer Prevention and Research Institute of Texas (PR170259)
Division of Cancer Prevention, National Cancer Institute (K99CA207736)
National Institute of Diabetes and Digestive and Kidney Diseases (R44 DK103377)
National Heart, Lung, and Blood Institute (HHSN268201600003C, HHSN268201600002C, HHSN268201600018C, HHSN268201600001C, HHSN268201600004C)
Text and Data Mining valid from 2019-04-06
Received: 11 October 2018
Accepted: 24 March 2019
First Online: 6 April 2019
Compliance with ethical standards
: Dr. Hébert owns controlling interest in Connecting Health Innovations, LLC (CHI), a company planning to license the right to his invention of the dietary inflammatory index (DIISuperscript removed) from the University of South Carolina to develop computer and smart phone applications for patient counseling and dietary intervention in clinical settings. Dr. Nitin Shivappa is an employee of CHI.
: The WHI protocol was approved by the Institutional Review Boards at the Clinical Coordinating Center (CCC) at the Fred Hutchinson Cancer Research Center (Seattle, WA) and at each of the participating Clinical Centers, and has, therefore, been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All participants provided written informed consent in accordance with the US Common Rule. This study was also approved as exempt category from the Institutional Review Boards at the University of South Carolina where the study was conducted.